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Effect of transient expression of the oestrogen receptor on constitutive and
inducible CYPlAl in Hs578T human breast cancer cells
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Summary Hs578T human breast cancer cells are an oestrogen receptor (ER)-negative cell line. Treatment of
these cells with 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) resulted in formation of a 6.9 S nuclear aryl
hydrocarbon (Ah) receptor complex, which bound to a [32P]dioxin-responsive element in a gel electrophoretic
mobility shift assay. However, TCDD does not induce CYPlAl gene expression or chloramphenicol acetyl
transferase (CAT) activity in cells transiently transfected with pRNHllc or pMCAT5.12, which are Ah-
responsive plasmids derived from the 5'-flanking region of the human and murine CYP1A1 genes respectively.
Restoration of Ah responsiveness was investigated by co-transfecting Hs578T cells with pRNH1 lc or
pMCAT5.12 and plasmids that express the ER (hER), Ah receptor (AhR) and AhR nuclear translocator
(Arnt) proteins. ER expression resulted in significantly increased basal CAT activity; however, TCDD did not
induce CAT activity in the transiently transfected cells. Expression of the AhR or Arnt proteins did not alter
basal or inducible CAT activity. Expression of N- or C-terminal truncated ER in Hs578T resulted in
differential regulation of Ah responsiveness. In Hs578T cells transiently expressing the ER, which contains C-
terminal deletions (amino acids 282-595), basal CAT activity was also increased; however, Ah responsiveness
was not restored. In contrast, transient expression of N-terminal-deleted (amino acids 1-178) ER resulted in a
marked decrease in basal CAT activity but a restoration of Ah responsiveness. These results suggest that basal
and inducible CAT activity in Hs578T cells transiently transfected with pRNHllc is modulated differentially
by ER domains that are present in the N- and C-terminal regions of the ER.
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The CYPlAI gene is a member of the cytochrome P450
superfamily and expression of this gene and related enzyme
activities have been extensively investigated (Nelson et al.,
1993). Inducibility of CYPlA1-dependent activities have been
correlated with increased susceptibilities to lung cancer, and
genetic polymorphisms in the CYPlAl gene may be
associated with adenocarcinoma and squamous cell carcino-
ma of the lung (Kellermann et al., 1973; Anttila et al., 1991;
Nakachi et al., 1993; Kelsey et al., 1994; Taioli et al., 1995).
It has also been suggested that CYPlAl-dependent aryl
hydrocarbon hydroxylase (AHH) activity may be a prog-
nostic indicator for breast cancer (Pyykk6 et al., 1991). The
induction of CYPlAl gene expression by aryl hydrocarbons
(Ahs) such as 3-methylcholanthrene (MC) and 2,3,7,8-
tetrachlorodibenzo-p-dioxin (TCDD) has been extensively
investigated (reviewed in Gonzalez and Nebert, 1985; Jones
et al., 1985; Fujisawa-Sehara et al., 1987; Foldes and
Bresnick, 1989; Hoffman et al., 1991; Burbach et al., 1992;
Ema et al., 1992; Reyes et al., 1992; Swanson and Bradfield,
1993; Whitlock, 1993; Whitelaw et al., 1993). A number of
structurally diverse compounds that bind to the intracellular
Ah receptor (AhR) induce CYPlAl and the molecular
biology of this response has been extensively investigated in
rodents, rodent and human liver cancer cell lines in culture
(Hoffman et al., 1991; Burbach et al., 1992; Ema et al., 1992;
Reyes et al., 1992; Whitelaw et al., 1993). The inducer
initially binds to the intracellular AhR, which undergoes
transformation to a heterodimer containing the AhR and the
AhR nuclear translocator (Arnt) proteins. The nuclear
AhR-Arnt complex acts as a transcription factor, which
binds genomic dioxin or xenobiotic responsive elements
(DREs or XREs), which are located in the 5'-flanking
region of the CYPlAl and other Ah-responsive genes
(Gonzalez and Nebert, 1985; Jones et al., 1985, 1986;
Fujisawa-Sehara et al., 1987).
Although ligand-induced transactivation of CYPlAl gene
expression requires interaction of the nuclear AhR complex
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with DREs, there are many other factors that modulate the
induction response. The induction of CYPlAI in several
different cell lines is enhanced by the protein synthesis
inhibitor, cycloheximide, suggesting that a labile inhibitory
protein may play a role in regulating transactivation of this
gene (Foldes and Bresnick, 1989; Nemoto and Sakurai,
1991; Lusska et al., 1992; Arellano et al., 1993). There is
also evidence for the role of other trans-acting factors that
can modulate induction of CYPlAI (Watson et al., 1992;
Gradin et al., 1993; Reick et al., 1994; Robertson et al.,
1994), including a negative regulatory element (NRE)
identified in the 5'-promoter region of the human and rat
CYPlAI gene (Hines et al., 1988; Boucher et al., 1993;
Sterling et al., 1993).
CYPlAl inducibility and polymorphisms may be an
important risk factor for lung and colorectal cancers
(Kellermann et al., 1973; Kawajiri and Fujiikuriyama, 1991;
Sivaraman et al., 1994) and basal CYPlA1-dependent
activities in breast tumours are reported to be negative
prognostic indicators for disease-free survival of women with
breast cancer (Murray et al., 1991; Pyykko et al., 1991);
Vickers et al., (1989) have suggested that induction of
CYP1Al in human breast cancer cells is related to their
oestrogen receptor (ER) content and studies with several
different human breast cancer lines indicate that Ah-
responsiveness correlates with expression of both the ER
and AhR (Jaiswal et al., 1985; Ivy et al., 1988; Pasanen et al.,
1988; Vickers et al., 1989; Thomsen et al., 1991,1994).
Moreover, several cell lines that express the AhR but are ER-
negative are not Ah-responsive and these include MDA-MB-
231, Hs578T and doxorubicin-resistant MCF-7 breast cancer
cells (Jaiswal et al., 1985; Ivy et al., 1988; Pasanen et al.,
1988; Harris et al., 1989; Vickers et al., 1989; Thomsen et al.,
1991,1994). A recent study from this laboratory (Thomsen et
al., 1994) showed that chloramphenicol acetyl transferase
(CAT) activity was induced by TCDD in MDA-MB-231 cells
transiently transfected with the human ER (hER) expression
plasmid and pRNH1Ic, an Ah-responsive plasmid containing
DREs derived from the 5'-regulatory region of the human
CYPlAl gene.
Since CYPlA1-dependent activity is a useful diagnostic
marker in mammary tumours, this study further investigatesCYPlAl expression in Hs578T cells
WL Wang et al
the role of the ER in restoring Ah responsiveness in the ER-
negative Hs578T human breast cancer cell line. The results
show that TCDD did not induce CYPlAI in this cell line;
however, the cells expressed the AhR and TCDD induced
formation of a 6.9 S nuclear AhR complex, which bound to a
DRE in a gel electrophoretic mobility shift assay. In transient
transfection studies with the hER expression and pRNH1 Ic
plasmid, there was a significant increase in the CAT activity.
Although the full-length hER did not restore Ah responsive-
ness in Hs578T cells, co-transfection with an N-terminal
truncated hER construct resulted in restoration of induci-
bility by TCDD. In contrast, both the full length hER and
the C-terminal truncated ER significantly increased basal
activity but did not affect Ah responsiveness.
Materials and methods
Chemicals and biochemicals
TCDD and 2,3,7,8-tetrachlorodibenzofuran (TCDF) (>99%
pure) were prepared in this laboratory. [3H]TCDD
(37 Ci mmol-') was prepared in this laboratory and purified
by high-pressure liquid chromatography (>98% pure). All
other chemicals and biochemicals were the highest quality
available from commercial sources.
Cell culture maintenance and growth
The Hs578T human breast cancer cells were obtained from
the America Type Culture Collection and maintained in
DME/F12 medium with phenol red and supplemented with
5% fetal bovine serum (FBS) plus 10 ml antibiotic/
antimycotic solution at 37°C.
Expression plasmids
The plasmid pRNHIlc contains the regulatory human
CYPlAl region from the Taql site at -1142 to the BcII
site at +2434 fused to the bacterial CAT reporter gene
(Hines et al., 1988). pRNH21c was derived from pRNHIlc
and is deleted from -831 to -560 (Hines et al., 1988). Both
of these plasmids were kindly provided by Dr R Hines
(Wayne State University, Detroit, MI, USA). pMCAT5.12 is
a construct containing the mouse DRE2 fused to the mouse
mammary tumour virus (MMTV) promoter driving the CAT
gene and was provided by Dr JP Whitlock (Stanford
University). The hER plasmid was a generous gift from Dr
Ming Jer Tsai (Baylor College of Medicine). This plasmid
contains the human ER cDNA. HE15 and HE19 are
expression vectors coding for mutant human ERs. In
HE15, the amino acids from 282 to 595 are deleted, whereas
HE19 is truncated from amino acids 1 to 178 (Kumar et al.,
1987). Arnt and AhR cDNAs were kindly provided by Drs
Bradfield and Hankinson (Burbach et al., 1992; Reyes et al.,
1992) and constructed into pcDNAI and pcDNA3 vectors
respectively.
Transient transfection assay
Cells were trypsinised, seeded in 100 mm Petri dishes with
5% FBS and phenol red-free DME/F12 medium, and grown
until 70% confluent, 5-10jIg of each plasmid and 20 pg
polybrene ml-' were used for each assay. After incubation
for 6 h, cells were shocked using 25% dimethyl sulphoxide
(DMSO) (Kawai and Nishizawa, 1984). After 18 h, cells were
treated with DMSO (0.2% total volume) or TCDD (10 nM)
in DMSO for 44 h. Cells were then washed with PBS and
scraped from the plates. Cell lysates were prepared in 0.16 ml
of 0.25 M Tris-HCl, pH 7.5, by three freeze-thaw-sonica-
tion cycles (3 min each). Protein concentrations were
determined by the Bradford method (Bradford, 1976) using
bovine serum albumin (BSA) as a standard. CAT activity was
determined using 0.2 mCi d-threo-[dichloroacetyl-1-'4C]chlor-
amphenicol and 4 mM acetyl CoA as substrates (Morgan et
al., 1986). Following thin-layer chromatography (TLC),
acetylated products were visualised and quantitated using a
Betascope 603 Blot analyser. CAT activity in various
treatment groups is expressed relative to that observed in
cells treated with DMSO alone. The experiments were carried
out at least in triplicate unless otherwise stated.
Gel mobility shift assay
Synthetic double-stranded human DRE oligonucleotides
(5'-GATCTGGCTCTTCTCACGCAACTCCG-3') (9 pmol)
were labelled at the 5' end using T4 polynucleotide kinase
and [y-32P]ATP (Maniatis et al., 1982; Denison and Deal,
1990). Aliquots of 5 jug of nuclear extract from control
(DMSO) and TCDD-treated cells were incubated in HEGD
[25 mM Hepes, 1.5 mM EDTA, 1.0 mM dithiothreitol, 10%
glycerol (v/v), pH 7.6] buffer with 1 ,ug of poly[d(I-C)] for
15 min at 20°C to bind non-specific DNA-binding proteins.
A hundred-fold excess of unlabelled wild-type and mutant
DRE were added for the competition experiments and
incubated at 20°C for 15 min. Following addition of [32p]
DNA, the mixture was incubated for an additional 15 min at
20°C. Reaction mixtures were loaded onto a 5% polyacry-
lamide gel and fractionated by electrophoresis at 110 V in
0.9 M Tris-borate and 2 mM EDTA, pH 8.0. Gels were dried
and protein-DNA complexes were visualised by autoradio-
graphy and scanned on a Betagen Betascope 603 Blot
analyser imaging system for quantitation of the retarded
bands.
Sucrose density gradient analysis
Nuclear extracts were isolated from Hs578T cells after
incubation of a cell suspension with 10 nM [3H]TCDD or
10 nM [3H]TCDD plus a 200-fold excess of TCDF as
described (Wang et al., 1992) and layered on linear sucrose
gradients (5-25%) prepared in HEGD plus 0.4 M potassium
chloride. Gradients were centrifuged at 404000 g at 3°C for
2.5 h. After the centrifugation 30 fractions were collected
from each gradient and radioactivity in each fraction was
determined to give the total binding.
Statistical analysis
Results are expressed as means+s.d. for at least three
separate determinations for each experiment. Statistical
significance was determined by ANOVA and Student's t-
test and the levels of probability are noted.
Results
After treatment of a suspension of Hs578T cells with 10 nM
[3H]TCDD for 2 h the nuclear extract was analysed by
sucrose density gradient centrifugation. The results sum-
marised in Figure 1 indicate that TCDD induces formation of
a specifically bound nuclear AhR complex that is similar to
that observed in other cell lines (Pasanen et al., 1988; Harris
et al., 1989; Vickers et al., 1989; Thomsen et al., 1991). The
results illustrated in Figure 2 show that nuclear extracts from
untreated (DMSO) cells do not form an AhR-DRE complex
with retarded mobility as determined in a gel electrophoretic
mobility shift assay. After treatment of the cells with 10 nM
TCDD, nuclear extracts formed a specific DNA-protein
band with retarded mobility, which was decreased in intensity
after incubation with 100-fold excess unlabelled DRE but was
essentially unchanged by co-incubation with a 100-fold excess
of unlabelled mutant DRE. Thus, the nuclear AhR that
forms in Hs578T cells after treatment with TCDD (Figure 1)
forms a complex with [32P]DRE that can be detected using a
gel retardation assay (Figure 2).
The effects of hER expression on restoration of Ah
responsiveness in Hs578T cells was investigated in cells co-
transfected with pRNHllc+hER. The results (Figure 3,
Table I) indicate that in cells transfected with pRNHI lc
alone (Figure 3, lane 1), TCDD treatment resulted in only aCYPlAI expression in Hs578T cells $_ WL Wang et at
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Figure 1 Velocity sedimentation analysis of the nuclear TCDD-
AhR complex in Hs578T cells. Cells in suspension were treated
with 10nm [3H]TCDD +2pM TCDF for 2h; the cells were then
collected, and nuclei were isolated, extracted and analysed by
velocity sedimentation analysis as described in Materials and
methods. Radiolabelled nuclear AhR complex sedimented at
6.9S. *, TCDD; 0, TCDD+TCDF.
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Figure 2 Gel mobility shift analysis of the AhR-DRE complex
from Hs578T human breast cancer cells. The cells were treated
with DMSO or 10lnM TCDD for 2h at 37°C and analysed by gel
electrophoretic mobility shift assay. Nuclear extracts from cells
treated with DMSO (lane 1), TCDD (lane 2), TCDD plus
competition with 100-fold excess of unlabelled DRE (lane 3) or
mutant DRE (lane 4) were used in this assay. The relative band
intensities in the specifically bound band (AhR-DRE complex)
were lane 1, 5.1+ 1.0; lane 2, 51.7+3.4; lane 3, 3.3+1.3; lane 4,
53.9+4.0.
1.6-fold induction of CAT activity (Figure 3, lane 2). In cells
co-transfected with the hER plasmid and pRNH1lc, CAT
activity in control (DMSO) cells was elevated 13.5-fold
(Figure 3, lane 11) compared with transfection in the absence
of hER. Co-transfection of hER and pRNH1Ic coupled with
treatment with 10 nM TCDD also resulted in significantly
increased CAT activity (Figure 3, lane 12); however, CAT
activity was induced < 1.6-fold by TCDD. The possible
restoration of Ah responsiveness in Hs578T cells was also
investigated by co-transfecting cells with Arnt, AhR, Arnt
plus AhR, Arnt plus AhR plus hER expression plasmids, and
pRNHIlc (Table I, Figure 3). Co-transfection of pRNHllc
with Arnt, AhR or Arnt plus AhR expression plasmids
resulted in no significant changes in basal CAT activity and
minimal induction by TCDD. Increased basal (but not
induced) CAT activity was only observed in cells transfected
with hER. A similar set of experiments was carried out using
pMCAT5.12, an Ah-responsive plasmid that contains DRE2
from the murine CYPIAI gene (Table II). TCDD did not
induce CAT activity in Hs578T cells transfected with
pMCAT5.12. Co-transfection of cells with pMCAT5.12 and
Arnt plus AhR expression plasmids did not affect basal or
inducible (TCDD) CAT activity. However, in cells treated
with DMSO and co-transfected with pMCAT5.12 with the
hER, hER plus Arnt, hER plus AhR or hER plus AhR plus
Arnt expression plasmids resulted in a 4- to 5-fold increase in
CAT activity. CAT activity was not significantly induced by
TCDD in the co-transfected Hs578T cells.
pRNH21c is derived from pRNH1 lc; however, the -831
to - 560 nucleotides containing the NRE sequence have been
deleted (Hines et al., 1988). A comparison of the effects of
hER on CAT activity in Hs578T cells co-transfected with
pRNH Ilc or pRNH21c was also determined (Figure 4). The
results obtained with pRNH ilc were similar to those
reported in Table I (Figure 4, lanes 1, 2, 5 and 6). In
contrast, CAT activity in Hs578T cells co-transfected with
pRNH21c+hER was not detected in control (DMSO) cells
or after treatment with TCDD.
The effects of hER and mutant hER plasmids with C-
terminal deletions of amino acids 282 to 595 (HE15) or N-
terminal deletions of amino acids 1-178 (HE19) on CAT
activity in Hs578T cells transfected with pRNH IIc were also
investigated. The results (Table III) showed that in control
(DMSO) cells co-transfected with pRNHIlc plus HE15 or
HE19 plasmids, there was a >2- and >47-fold decrease in
CAT activity respectively, compared with cells co-transfected
with pRNHIlc plus hER. In Hs578T cells co-transfected
with pRNHlc plus hER, HE15 or HE19 the effects of
TCDD were dependent on the expressed ER or ER fragment.
The results obtained using hER (full length) or HE15 were
similar and CAT activity induced by TCDD was < 1.5-fold
whereas a >23-fold induction response was observed with
HE19.
Discussion
Studies in this laboratory have focused on determining the
regulation of Ah responsiveness in human breast cancer cell
lines using induction of CYPlAI and inhibition of oestrogen-
induced gene expression as models (Harris et al., 1989;
Arellano et al., 1993; Moore et al., 1993; Wang et al., 1993;
Thomsen et al., 1994; Chaloupka et al., 1995). Several reports
suggest that induction of CYPlAI in human breast cancer
cells by AhR agonists requires a functional ER (Jaiswal et
al., 1985; Ivy et al., 1988; Pasanen et al., 1988; Harris et al.,
1989; Thomsen et al., 1991,1994). MDA-MB-231 cells are
ER negative and Ah non-responsive; however, co-transfec-
tion of the hER plus the Ah-responsive pMCAT5.12 or
pRNH1lc plasmids resulted in a significant induction of
CAT activity by TCDD (Thomsen et al., 1994). Moreover, in
a series of experiments that decrease transiently expressed
ER, there was a corresponding decrease in Ah responsive-
ness. Hs578T cells have previously been characterised as ER
negative and TCDD does not induce CYPlAI-dependent+
CYPlAl expression in Hs578T cells
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Figure 3 Effects of human AhR, Arnt and ER on restoration of Ah responsiveness in Hs578T human breast cancer cells. The cells were
transiently transfected with 5 Mg of pRNHllc (lanes 1 to 12) and co-transfected with 5 Mg of other expression plasmids for each different
experiment. Lanes 1, 3, 5, 7, 9 and 11 were derived from cells treated with DMSO, whereas lanes 2, 4, 6, 8, 10 and 12 were treated with
10nM TCDD for 44h. The various treatments are indicated in the Figure 3 and quantitation of induced CAT activities are summarised in
Table I.
Table I Comparative effects of human AhR, Arnt and hER
expression plasmids on restoring Ah responsiveness to
THsS78Tcells by transient co-transfection studies with the
pRNHlIc plasmida
Relative CAT activity
Transfectedplasmids DMSO TCDD
pRNHllc 1 1.6+0.2
pRNHllc+Arnt 1.9+0.2 2.7+0.3
pRNHllc+AhR 1.0+0.1 3.0+0.4
pRNHllc+Arnt+AhR 1.5+0.3 2.2+0.5
pRNHllc+Arnt+AhR+hER 15.6+ 1.7b 19.6+0.9b
pRNHllc+hER 13.5+1.2b 20.5+0.8b
a The cells were transfected with 5Mg of each plasmid for each
individual group, shocked with 25% DMSOanddosedwith DMSO or
10nM TCDD for 44h and standardised against DMSO-treated
Hs578T cells that were transfected with pRNHllc plasmid alone.
b Statistically higher (P<0.01) than DMSO-treated Hs578T cells
transfected with pRNH1 lc.
Table II Comparative effects of human AhR, Arnt and hER
expression plasmids on restoring Ah responsiveness to Hs578T cells
by transient co-transfection studies with the pMCAT5.12 plasmida
Relative CAT activity
Transfectedplasmids DMSO TCDD
pMCAT5.12 1 1.1 +0.3
pMCAT5.12+hER 5.4+0.5b 6.7+0.6b
pMCAT5.12 +hER+Amt 4.1 +0.6b 5.4+o.5b
pMCAT5.12 +hER+AhR 5.0+0.3b 5.6+0.3b
pMCAT5.12+Arnt+AhR 1.3 +0.2 1.4+0.3
pMCAT5.12 +Arnt+AhR+hER 4.3 +0.7b 6.1 +0.6b
a The cells were transfected with 5,g of each plasmid for each
individual group, shocked with 25% DMSO and dosed with DMSO or
10nM TCDD for 44h and standardised against DMSO-treated
Hs578T cells that were transfected with pMCAT5.12 plasmid alone.
b Statistically higher (P<0.01) than DMSO-treated Hs578T cells
transfected with pMCAT5.12.
activity in this cell line (Arellano et al., 1993). However,
nuclear extracts from cells treated with [3H]TCDD or
unlabelled TCDD form a specifically bound 6.9 S nuclear
AhR complex (Figure 1) that binds to a [32P]DRE to give a
band with retarded mobility in a gel electrophoretic mobility
shift assay (Figure 2). These results suggest that the Ah non-
responsiveness of Hs578T cells is not due to the failure of
these cells to express the AhR and form a nuclear 6.9 S AhR
complex or to interact with DREs. The results are in contrast
to mutant benzo[a]pyrene-resistant MCF-7 breast cancer cells
that also express the nuclear AhR but do not bind to a DRE
(Moore et al., 1993). The failure of the AhR to form a DRE
complex is consistent with the Ah non-responsiveness of the
mutant MCF-7 cells; however, the results obtained with
Hs578T cells indicate that other factors must be associated
with the failure to observe an induction response with
TCDD. Since cycloheximide treatment of Hs578T cells also
does not restore induction of CYPlAl mRNA levels by
TCDD (Arellano et al., 1993), it is unlikely that a labile
protein or related factor is involved in the repressed
induction response.
The effects of ER expression on Ah responsiveness in
Hs578T cells were investigated by co-transfecting an hER
expression plasmid with pRNH1 Ic that contains the - 1142
to +2434 sequence from the human CYPlAl gene fused to a
bacterial CAT reporter gene (Hines et al., 1988). The results
(Figure 3 and Table I) show that transient ER expression
significantly increases basal CAT activity in untreated
(DMSO) cells; however, induction of CAT activity by
TCDD was minimal. In a series of transient transfection
studies using expression plasmids for Arnt, AhR and ER or
their combinations, the major response was a significant
increase in basal CAT activity only in the presence ofhER; in
contrast, minimal induction of CAT activity by TCDD was
observed. Similar results were obtained using pMCAT5.12,
an Ah-responsive plasmid that contains the murine DRE2
but not the extensive 5'-regulatory DNA fragment associated
with the pRNHIlc plasmid. These data are in contrast to
previous transient transfection studies with MDA-MB-231
cells in which transient expression of ER restored Ah respon-
siveness with both pRNHllc and pMCAT5.12 plasmids but
did not affect basal CAT activity (Thomsen et al., 1994).
Preliminary studies with MDA-MB-231 cells also show that
the Arnt expression plasmid also partially restores Ah
responsiveness (unpublished results) whereas this was not
observed in Hs578T cells co-transfected with the Arnt
expression plasmid (Tables I and II).
An NRE has been identified in the 5'-promoter of the
human CYPlAI gene (-833 to -558) (Hines et al., 1988;
Boucher et al., 1993) and the pRNH21c construct has the
NRE sequence deleted. In transient transfection studies with
Hep G2 human hepatoma cells with both pRNH1 lc and
pRNH11c
Arnt
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ERCYPlAl expression in Hs578T cells
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Figure 4 Effects of hER expression on restoration of Ah responsiveness by co-transfection with pRNHl lc or pRNH21C. Aliquots
of 5jMg of each plasmid were used for transient transfection. Lanes 1, 3, 5 and 7 were treated with DMSO, whereas lanes 2, 4, 6 and
8 were treated with 10 nM TCDD for 44h. Relative CAT activities observed in cells transiently transfected with pRNHllc+hER
and pRNH21c+hER were 1.0+0.2 (DMSO) and 1.1+0.1 (TCDD) and 0.04+0.01 (DMSO) and 0.04+0.005 (TCDD) respectively.
CAT activities in cells transfected with pRNH21c alone were not significantly different than results obtained in cells co-transfected
with pRNH21c+hER.
Table III Comparative effects of human wild- and mutant-type ER
expression plasmids on restoring Ah responsiveness to Hs578Tcells
by transient co-transfection studies with Ah-responsive pRNHlIc
plasmida
Relative CAT activity
Transfectedplasmids DMSO TCDD
pRNHllc+hER 100 151.9b
pRNHllc+HE15 .9b 51.9b
pRNHllc+HE19 2.lb 48.9b
a The cells were transfected with 5pg of each plasmid for each
individualgroup, shockedwith 25% DMSOanddosedwithDMSO or
10nM TCDD for 44h and standardised against DMSO-treated
Hs578T cells that were co-transfected with pRNHllc plasmid alone
and the full-length or truncated ERexpressionplasmids. b Statistically
higher(P<0.01) thanDMSO-treated Hs578Tcellsco-transfected with
pRNHlIc plus ER plasmids.
pRNH21c, there was an 8.4-fold increase in basal CAT
activity after deletion of the NRE and this was accompanied
by a significant decrease in the fold induction of CAT activity
by polynuclear aromatic hydrocarbons using pRNH21c
(Hines et al., 1988). Based on these results from Hep G2
cells, it was hypothesised that in Hs578T cells, ER expression
may derepress the effects of the NRE on the basal activity of
the CYPlAl promoter. However, a comparison of basal and
induced CAT activity in Hs578T cells co-transfected with
hER plus pRNHl lc or pRNH21c indicates that CAT activity
was minimal using the NRE-deleted pRNH21c in the
presence or absence of TCDD (Figure 4). These results
illustrate differences in the role of the NRE and/or NRE-
associated proteins in promoter-dependent regulation of
CYPlAl in Hs578T human breast cancer and Hep G2
human hepatoma cell lines.
The ER contains several structural domains, including at
least two important transactivation regions, TAFI and
TAF2, that are associated with constitutive and ligand-
inducible activities respectively (Kumar et al., 1987). Previous
studies with MDA-MB-231 cells co-transfected with
pRNHIlc plus hER, HE15 or HE19 showed that Ah
responsiveness was restored by expression of either the full
length or both truncated ERs (Thomsen et al., 1994). The
results summarised in Table III demonstrate that using the
same experimental design with Hs578T cells gave results that
were in contrast to those reported for MDA-MB-231 cells.
Expression of C-terminal-deleted ER (HE15) in Hs578T cells
increased basal CAT activity but not Ah responsiveness,
whereas expression of the N-terminal-deleted ER (HEl9)
resulted in a >47-fold loss of basal activity but restoration of
Ah responsiveness, since TCDD caused a 23-fold increase in
CAT activity. These results suggest that in Hs578T cells, the
various domains of the ER play a differential role in
restoration of Ah responsiveness. The predominant effect of
the ER and the C-terminal-deleted ER is to increase basal
but not inducible activity regulated by the CYPlAI promoter
in pRNH1Ic. However, expression of N-terminal-deleted ER
(HE19) resulted in a dramatic loss of basal CAT activity but
restoration of Ah responsiveness in Hs578T cells co-
transfected with pRNH1 lc plus HE19 (Table III). Thus,
expression of amino acids 179 to 595 of the ER is sufficient to
restore Ah responsiveness to Hs578T cells and eliminate the
overriding ER-mediated increase in basal activity, which
appears to be primarily associated with the N-terminal
portion of the ER. Previous studies have reported higher
basal or constitutive expression of CYPlAl in some breast
tumours and this elevated response may be useful as a
negative prognostic indicator for breast cancer (Murray et al.,
1991; Pyykko et al., 1991). The results observed in this study
with Hs578T cells demonstrate that expression of the full-
length or C-terminal-deleted ER significantly increases
constitutive CYPlAl activity. It has recently been reported
that exon 5 deletion variant ER (A5ER) mRNA is
overexpressed in some tumours and the resulting protein
contains TAF-1 but lacks TAF-2 and the ligand-binding
domain of the ER (Fuqua et al., 1993; Daffada et al., 1995;
Villa et al., 1995). These observations are consistent with the
enhancement of basal CYPlAl-dependent activity in Hs578T
cells by HE15, which is functionally similar to A5ER and
suggests that future studies on the linkage between expression
of L5ER and high basal CYPlAl activity in breast tumours
is warranted.
pRNH11c
pRNH21c
ER
+
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In summary, the results of this study with ER-negative
Hs578T cells illustrate that regulation of CYPlAl is highly
variable in human breast cancer cell lines. The restoration of
Ah responsiveness in Hs578T cells by truncated ER-encoding
amino acids 179 to 595 suggests that the ligand-dependent
TAF-2 (Kumar et al., 1987) may play an important role in
this response. Current studies in this laboratory are focused
on delineating the cell-specific regulation of CYPlAl in ER-
positive and ER-negative human breast cancer cells and
delineating the protein-protein and protein-DNA interac-
tions that are required for transactivation of CYPlAl.
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